Status:
COMPLETED
Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease
Lead Sponsor:
Cairo University
Conditions:
Coronary Artery Disease
Statin Adverse Reaction
Eligibility:
All Genders
18-80 years
Brief Summary
In the present cross-sectional observational study, the investigators aimed to: * Evaluate the prevalence of achievement of LDL-C targets among a sample of Egyptian ASCVD patients. * Attempt to unvei...
Detailed Description
There is a huge gap between guideline recommendations and real-world data concerning LDL-C targets for coronary artery disease CAD patients. This large gap highlights the need to improve the utilizati...
Eligibility Criteria
Inclusion
- Patients presenting to cardiology department/ outpatient clinic.
- Established ASCVD and eligible for high intensity statins for at least six-months.
- Age between18-to-80y.
Exclusion
- Refusal to participate in the survey.
- Recent diagnosis of ASCVD with indication to high intensity statins for a period \< six-months.
- Patients with medical limitation or contraindications to statins therapy.
- Patients with documented diagnosis of homozygous familial hypercholesterolemia.
Key Trial Info
Start Date :
September 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06897566
Start Date
September 21 2024
End Date
November 1 2025
Last Update
December 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Cairo University
Cairo, Egypt
2
Faculty of Medicine, Cairo University
Cairo, Egypt